Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases

Press/Media

Period	26 Oct 2023

Media coverage

Title	Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases
Media name/outlet	BioSpace
Country/Territory	United States
Date	26/10/23
URL	ct.moreover.com/?a=52173428712&p=1gw&v=1&x=NnCj1kJ7K52iROQBjsWIdg
Persons	Howard Fillit